- Book
- April 2019
- 191 Pages
- Report
- September 2022
- 141 Pages
Global
From €2289EUR$2,499USD£1,949GBP
€3269EUR$3,570USD£2,784GBP
- Report
- April 2022
- 189 Pages
Global
From €2285EUR$2,496USD£1,946GBP
€3265EUR$3,565USD£2,780GBP
- Book
- March 2021
- 192 Pages
- Book
- May 2016
- 512 Pages
- Book
- April 2015
- 384 Pages
- Book
- April 2014
- 744 Pages
- Book
- November 2011
- 496 Pages
Global
- Book
- April 2008
- 160 Pages

Alzheimer's Disease is a neurological disorder that affects memory, thinking, and behavior. It is the most common form of dementia, a group of disorders that cause a decline in cognitive function. Symptoms of Alzheimer's Disease include memory loss, difficulty with problem-solving, and changes in behavior. As the disease progresses, individuals may experience difficulty with language, disorientation, and difficulty with daily activities.
The Alzheimer's Disease market is a subset of the larger Neurology market. It is a rapidly growing market, driven by an aging population and increased awareness of the disease. Companies in the market are focused on developing treatments and therapies to improve the quality of life for those affected by the disease.
Companies in the Alzheimer's Disease market include Biogen, Eli Lilly, Novartis, and Roche. Other companies in the market include AbbVie, AstraZeneca, Merck, and Pfizer. Show Less Read more